These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25969543)

  • 1. Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.
    Daniele SG; Béraud D; Davenport C; Cheng K; Yin H; Maguire-Zeiss KA
    Sci Signal; 2015 May; 8(376):ra45. PubMed ID: 25969543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo.
    Dutta D; Jana M; Majumder M; Mondal S; Roy A; Pahan K
    Nat Commun; 2021 Sep; 12(1):5382. PubMed ID: 34508096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    Rajalakshmy AR; Malathi J; Madhavan HN
    PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes increases the susceptibility to acute kidney injury after myocardial infarction through augmented activation of renal Toll-like receptors in rats.
    Ohno K; Kuno A; Murase H; Muratsubaki S; Miki T; Tanno M; Yano T; Ishikawa S; Yamashita T; Miura T
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1130-H1142. PubMed ID: 28822965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation.
    Khan J; Sharma PK; Mukhopadhaya A
    Immunobiology; 2015 Nov; 220(11):1199-209. PubMed ID: 26093918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.
    Joseph AM; Srivastava R; Zabaleta J; Davila E
    Cancer Immunol Res; 2016 Aug; 4(8):708-16. PubMed ID: 27267778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
    Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein induces prodromal symptoms of Parkinson's disease via activating TLR2/MyD88/NF-κB pathway in Schwann cells of vagus nerve in a rat model.
    Cheng Y; Tong Q; Yuan Y; Song X; Jiang W; Wang Y; Li W; Li Y; Zhang K
    J Neuroinflammation; 2023 Feb; 20(1):36. PubMed ID: 36788559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin.
    Kong X; Wu SH; Zhang L; Chen XQ
    Mol Med Rep; 2015 Jul; 12(1):895-904. PubMed ID: 25760938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.
    Jeon JH; Lee HR; Cho MH; Park OK; Park J; Rhie GE
    Infect Immun; 2015 Oct; 83(10):3847-56. PubMed ID: 26195551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia.
    Zeng KW; Zhang T; Fu H; Liu GX; Wang XM
    Eur J Pharmacol; 2012 Oct; 692(1-3):29-37. PubMed ID: 22698579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
    Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM
    Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidoglycan enhances proinflammatory cytokine expression through the TLR2 receptor, MyD88, phosphatidylinositol 3-kinase/AKT and NF-kappaB pathways in BV-2 microglia.
    Lin HY; Tang CH; Chen YH; Wei IH; Chen JH; Lai CH; Lu DY
    Int Immunopharmacol; 2010 Aug; 10(8):883-91. PubMed ID: 20451669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycoplasma bovis-derived lipid-associated membrane proteins activate IL-1β production through the NF-κB pathway via toll-like receptor 2 and MyD88.
    Wang Y; Liu S; Li Y; Wang Q; Shao J; Chen Y; Xin J
    Dev Comp Immunol; 2016 Feb; 55():111-8. PubMed ID: 26499291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.
    Kim C; Ho DH; Suk JE; You S; Michael S; Kang J; Joong Lee S; Masliah E; Hwang D; Lee HJ; Lee SJ
    Nat Commun; 2013; 4():1562. PubMed ID: 23463005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
    Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM
    Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
    Zhang QS; Heng Y; Yuan YH; Chen NH
    Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological roles of α-synuclein in neurological disorders.
    Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
    Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling.
    Grabowski M; Murgueitio MS; Bermudez M; Wolber G; Weindl G
    Biochem Pharmacol; 2020 Jan; 171():113687. PubMed ID: 31678495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.